German molecular Dx company obtains $16.3M in financing

04/23/2013 | GenomeWeb Daily News (free registration)

Curetis has raised $16.3 million in Series B financing, which it will use to support its operational and commercial expansion. The Germany-based firm plans to submit an FDA 510(k) clearance application next year for its Unyvero system, a DNA-based diagnostics platform that can detect multiple antibiotic-resistant organisms and bacteria from a single sample in one go.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC